MiR-103 protects from recurrent spontaneous abortion via inhibiting STAT1 mediated M1 macrophage polarization

Xiaoxiao Zhu1, Haiping Liu2, Zhen Zhang1

  • 1Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 18877 Jingshi Road, Jinan 250062, Shandong, China.

Insights

Decreased miR-103 levels are linked to recurrent spontaneous abortion (RSA) by promoting M1 macrophage polarization. This microRNA may serve as a diagnostic marker and therapeutic target for RSA.

Area of Science:

  • Immunology
  • Reproductive Biology
  • Molecular Biology

Background:

  • Recurrent spontaneous abortion (RSA) is a common pregnancy complication.
  • M1 macrophages are implicated in RSA pathogenesis, but mechanisms are unclear.
  • MicroRNAs regulate macrophage polarization and are involved in RSA.

Purpose of the Study:

  • Investigate the role of microRNAs in M1 macrophage differentiation in RSA.
  • Determine the regulatory effect of miR-103 on M1 polarization in RSA.
  • Explore miR-103 as a potential diagnostic and therapeutic target for RSA.

Main Methods:

  • MiRNA microarray and qRT-PCR to analyze miR-103 expression in RSA patients and macrophages.
  • In vitro experiments to assess the effect of miR-103 overexpression/inhibition on M1 polarization and STAT1/IRF1 pathway.
  • In vivo studies in mice to evaluate the impact of miR-103 on embryo resorption and M1 polarization.

Main Results:

  • miR-103 was significantly decreased in M1 macrophages and RSA patients, correlating negatively with STAT1.
  • Down-regulation of miR-103 effectively discriminated RSA from normal pregnancies.
  • Overexpression of miR-103 suppressed M1 polarization by inhibiting the STAT1/IRF1 pathway; miR-103 directly targets STAT1.
  • In vivo, miR-103 overexpression reduced embryo resorption and M1 polarization.

Conclusions:

  • Decreased miR-103 contributes to RSA by enhancing M1 macrophage polarization via the STAT1/IRF1 pathway.
  • miR-103 shows potential as a diagnostic biomarker for RSA.
  • miR-103 represents a promising therapeutic target for managing RSA.